Kodiak Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Kodiak Sciences

15/11/2024 12:00

* Kodiak Sciences Inc  KOD.OQ  reported a quarterly adjusted
loss
of 84 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -95 cents.  The mean expectation of six analysts
for the quarter was for a loss of 90 cents per share. Wall
Street expected results to range from -100 cents to -82 cents
per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kodiak Sciences Inc's reported EPS for the quarter was a
loss
of 84 cents​.
    * The company reported a quarterly loss of $43.95 million.
    * Kodiak Sciences Inc shares had risen by 103.1% this
quarter and
gained 74.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Kodiak Sciences
Inc is 3.50 
This summary was machine generated from LSEG data November 15 at
11:59 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.90          -0.84          Beat
 Jun. 30 2024      -0.87          -0.86          Beat
 Mar. 31 2024      -1.07          -0.82          Beat
 Dec. 31 2023      -0.77          -1.13          Missed